Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

SS
SS Innovations wins 2026 Surgical Robotics Industry Awards

SS Innovations International named Outstanding Company at 2026 SRIA, beating nine finalists. This achievement underlines the competitive differentiati...

KENNAMETAL
Kennametal Appoints Cole as Vice President and CHRO

Kennametal Inc. announced the appointment of Amanda Cole as Vice President and Chief Human Resources Officer to succeed Judith Bacchus. This leadershi...

Empery
Empery Digital amends subsidiary LLC agreement.

Empery Digital Inc. filed an amended LLC agreement for subsidiary EmHu, LLC. The filing outlines updated governance terms and financial provisions for...

HCW
HCW Biologics Regains Nasdaq Compliance and Executes One-for-Six Split

The company regained compliance with Nasdaq's bid price rule after completing a mandatory one-for-six reverse stock split. This reinstatement is subje...

Microbot
Microbot expands manufacturing via Sanmina partnership

Microbot Medical entered a strategic agreement with Sanmina to manufacture the LIBERTY System to meet global demand. This partnership aims to lower co...

Moleculin
Moleculin Annamycin outperforms control in pivotal AML trial

Moleculin reported positive interim results from its MIRACLE trial, showing Annamycin achieved three-fold higher complete remission rates than the con...

Moleculin
Moleculin Biotech Files Exhibit 99.1

Moleculin Biotech has filed an exhibit with the SEC, usually containing supplementary information such as a press release. Investors should review thi...

Vistagen
Vistagen's Fasedienol misses primary Phase 3 endpoints for social anxiety.

Vistagen Therapeutics notified investors that its intranasal social anxiety drug failed to meet primary and secondary endpoints in the PALISADE-4 tria...

Innventure,
Innventure signs consulting agreement with former CEO

Former CEO Gregory Haskell agreed to provide transition services through April 30, 2027, in exchange for continued equity vesting and COBRA health cov...

Nauticus
Nauticus to exchange existing securities for Series C preferred stock

Nauticus Robotics entered an exchange agreement to swap existing secured term loans for Series C preferred stock. This debt-for-equity transaction aim...

Sharplink,
Sharplink acquires ETH and repurchases 2.1M shares.

Sharplink acquired 10,000 ETH and repurchased 2.13 million shares while raising $75 million in a registered direct offering. This execution reinforces...

Cartesian
Cartesian Growth Corp IV agrees to 25M unit sale at $10

The company entered an underwriting agreement with Cantor Fitzgerald to sell 25 million units at $10.00 per unit. This capital raise is essential for ...

LCI
LCI and Patrick Sign Definitive Merger Agreement

LCI Industries and Patrick Industries entered into a definitive merger agreement. This transaction outlines the structure and timeline for the combina...

Air
APD cancels LCEC project, expects Q3 pre-tax charge of $2.9B

Air Products will exit the LCEC project, incurring a $2.9 billion pre-tax charge driven by economic conditions and slower market development. The comp...

LQR
LQR House inked partnership with ByteDance for AI computing

LQR House inked a two-year agreement with BytePlus to deploy advanced AI computing power. This strategic investment aims to enhance quantitative resea...

Akebia
Akebia halts VOICE trial citing improved safety for Vafseo over ESAs

USRC and Akebia halted the VOICE trial due to improved safety outcomes with Vafseo compared to ESAs. The interim data indicates a significant reductio...

QXO,
QXO completes tender offer for nearly $1.25B of TopBuild debt

QXO has accepted for purchase nearly $1.25 billion of TopBuild Corp.'s senior notes, representing over 99% of the outstanding principal. This successf...

Vivani
Vivani Medical Files Amended and Restated Incentive Plan

Vivani Medical Inc. filed an amended and restated 2022 omnibus incentive plan to authorize grants of stock awards to officers and directors. This gove...

Blue
Blue Acquisition Corp amends merger deal with Blockfusion USA

Blue Acquisition Corp amended its business combination agreement with Blockfusion USA to add earnout provisions and reduce the post-merger board count...

Stoke
Stoke completes Zorevunersen Phase 3 enrollment

Stoke Therapeutics reported completing enrollment for the zorevunersen Phase 3 EMPEROR study involving 162 patients. The biotech firm plans a U.S. NDA...